2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | LEUKEMIA & LYMPHOMA LEUKEMIA LYMPHOMA (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.6
51人评分
我要评分
声誉 7.6 影响力 5.3 速度 9.7 | |||||||||||||||||||||||||
期刊ISSN | 1042-8194 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
E-ISSN | 1029-2403 | |||||||||||||||||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 2.6 点击查看影响因子趋势图 | |||||||||||||||||||||||||
实时影响因子 | 截止2024年3月26日:1.772 | |||||||||||||||||||||||||
2022-2023自引率 | 3.80%点击查看自引率趋势图 | |||||||||||||||||||||||||
五年影响因子 | 2.7 | |||||||||||||||||||||||||
h-index | 82 | |||||||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||
期刊官方网站 | http://informahealthcare.com/journal/lal | |||||||||||||||||||||||||
期刊投稿网址 | http://mc.manuscriptcentral.com/glal | |||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足LEUKEMIA & LYMPHOMA的语言要求,还能让LEUKEMIA & LYMPHOMA编辑和审稿人得到更好的审稿体验,让稿件最大限度地被LEUKEMIA & LYMPHOMA编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||
通讯方式 | TAYLOR & FRANCIS LTD, 4 PARK SQUARE, MILTON PARK, ABINGDON, ENGLAND, OXON, OX14 4RN | |||||||||||||||||||||||||
出版商 | Informa Healthcare | |||||||||||||||||||||||||
涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||
出版年份 | 1989 | |||||||||||||||||||||||||
年文章数 | 263点击查看年文章数趋势图 | |||||||||||||||||||||||||
Gold OA文章占比 | 13.00% | |||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 82.89% | |||||||||||||||||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:3区
| |||||||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1042-8194%5BISSN%5D | |||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均1.8月 | |||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约66.66% | |||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在LEUKEMIA & LYMPHOMA顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | YY1-induced LncRNA-TUG1 elevates YOD1 to promote cell proliferation and inhibit bortezomib sensitivity in multiple myeloma Author: Yin, Qingqing; Shen, Xianjuan; Xu, Honglei; Feng, Wei; Shi, Xiuying; Ju, Shaoqing Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10428194.2023.2200516 PubMed DOI |
2. | Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma Author: Ma, Guangyu; Gao, Yuhuan; Jing, Xiaotong; He, Cuiying; Liu, Haisheng; Wu, Xiaolin; Gao, Zhe; Li, Yuan; Zhang, Shengnan; Zhao, Guimin Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 140-150. DOI: 10.1080/10428194.2022.2131427 PubMed DOI |
3. | IFN-gamma enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway Author: Shao, Xiaoya; Meng, Xueqiong; Yang, Haiping; Wang, Xinxin; Qin, Ling; Shen, Guomin; Xi, Xiaoping; Zhao, Huijuan; Macip, Salvador; Chen, Yixiang Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 71-78. DOI: 10.1080/10428194.2022.2131408 PubMed DOI |
4. | Circulating mitochondrial DNA is associated with anemia in newly diagnosed hematologic malignancies Author: Yue, Liang; Li, Yu-Hang; Ma, Rui-Lin; Niu, Jing-Wen; Cui, Hong-Tu; Sun, Yao; Yun, Zhi-Min; Zhuo, Hai-Long; Wan, Lu-Ming; Li, Su-Bo; Zhang, Xue; Wu, Cheng-Jun; Hu, Liang-Ding; Tan, Ying-Xia Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 1, pp. 178-187. DOI: 10.1080/10428194.2022.2133537 PubMed DOI |
5. | The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia Author: Wang, Jun; Sun, Kai; Chen, Wen-Min; Wang, Xu; Li, Ling-Di; Hao, Yue; Xu, Nan; Jiang, Hao; Xu, Lan-Ping; Wang, Yu; Zhang, Xiao-Hui; Huang, Xiao-Jun; Jiang, Qian; Qin, Ya-Zhen Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 698-706. DOI: 10.1080/10428194.2022.2164193 PubMed DOI |
6. | Salinomycin sodium exerts anti diffuse large B-cell lymphoma activity through inhibition of LRP6-mediated Wnt/beta-catenin and mTORC1 signaling Author: Li, Liangliang; Zeng, Pengyun; Yu, Lili; Yang, Jincai; Man, Jiancheng; Zhou, Lanxia; Zhao, Li Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. , Issue , pp. -. DOI: 10.1080/10428194.2023.2202291 PubMed DOI |
7. | CDK7 inhibition induces apoptosis in acute myeloid leukemia cells and exerts synergistic antileukemic effects with azacitidine in vitro and in vivo Author: Zhang, Shuai; Feng, Ru; Bai, Jiefei; Ning, Shangyong; Xu, Xiaodong; Sun, Jie; Wu, Meng; Liu, Hui Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 639-650. DOI: 10.1080/10428194.2023.2169045 PubMed DOI |
8. | Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma Author: Lin, Meng; Wu, Xiaolong; Zhang, Lei; Li, Ling; Wang, Xinhua; Fu, Xiaorui; Sun, Zhenchang; Zhang, Xudong; Zhu, Linan; Yu, Hui; Chang, Yu; Nan, Feifei; Yan, Jiaqin; Zhou, Zhiyuan; Shi, Cunzhen; Zhang, Mingzhi; Li, Xin Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 3, pp. 605-612. DOI: 10.1080/10428194.2023.2167492 PubMed DOI |
9. | Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma Author: Li, Shuchan; Zheng, Gaofeng; He, Jingsong; Wu, Wenjun; Chen, Qingxiao; Yang, Yang; He, Donghua; Zhao, Yi; Han, Xiaoyan; Cai, Zhen Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 4, pp. 835-845. DOI: 10.1080/10428194.2023.2172982 PubMed DOI |
10. | Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in MDS Author: Pan, Danqi; Zhao, Wenshu; Jiang, Qianli; Yin, Changxin; He, Han; Liao, Libin; Ye, Jieyu; Dai, Min Journal: LEUKEMIA & LYMPHOMA. 2023; Vol. 64, Issue 4, pp. 856-864. DOI: 10.1080/10428194.2023.2185086 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共2条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451